| Ytd | -2.20% | |
| 1y | -2.20% |
| Open | 0.82 | Prev Close | 0.80 | Low | 0.79 | High | 0.83 | Mkt Cap | 10.62M |
| Vol | 40.06K | Avg Vol | 10.56M | EPS | -0.80 | P/E | -1.00 | Forward P/E | -1.15 |
| Beta | 0.57 | Short Ratio | 0.25 | Inst. Own | 5.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 0.80 | 200-d Avg | 1.11 | 1yr Est | 4.50 |
HOTH News
Hoth Therapeutics stock surged after announcing its Rocket One rebrand and new AI chip technology fo
Company Adopts Space-Focused Identity, New Ticker "RKTO," and Exclusive License of AI Chip Architect
Allowed Claims Cover Composition-of-Matter and Methods Targeting MS4A6A Pre-mRNA Splicing to Reduce
Company Targets Power Demands of AI Data Centers Through Patented Nanomagnetic Semiconductor and Spi
Regulatory Clearance in Spain Advances Randomized, Placebo-Controlled Study; Patients Show Meaningf
Statistically Significant Reduction in Srebf1 (Fat Production) and Increased Pparα (Fat Metabolism)
Statistically Significant Reduction in Srebf1 (Fat Production) and Increased Pparα (Fat Metabolism)
NEW YORK, April 2, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a clinical-stage bio
NEW YORK, April 1, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a clinical-stage bio
Over 65% of Patients Reported Reduced Pain and Itching; Zero Disruptions to EGFR Cancer Therapy with
Technology Selectively Shuts Down Cancer Reproducing Cells Patent Covers Splice-Switching Oligonucle
NEW YORK, March 26, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage bi
PK studies of topical HT-001 reveal limited systemic absorption and ~99% reduced systemic levels as
HT-VA restores cholesterol to control-diet levels and maintains lower triglycerides compared with se
AI Integration Supports IND Preparation & Phase 1 Progression for Rare KIT-Driven Cancers NEW YORK,
CLEER-001 Phase 2a Expansion Signals Growing Momentum Behind First-in-Class Therapy for Cancer Patie
In a head-to-head preclinical comparison, HT-VA co-developed with the United States Veterans Adminis
Hoth Therapeutics Inc. (NASDAQ: HOTH) on Tuesday revealed preclinical data from its study on glial c
NEW YORK, Feb. 5, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biop
Primary endpoint ARIGA improved by ~50% from baseline by Week 6, with all evaluable patients reachin
On Thursday, 369 companies hit new 52-week lows.
On Monday, 369 companies set new 52-week lows.
Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Tech
On Wednesday, 345 companies set new 52-week lows.
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 105% to $0.1730 after the compan
Tuesday's session saw 286 companies set new 52-week lows.
On Monday, 198 companies hit new 52-week lows.
Thursday's session saw 337 companies set new 52-week lows.
On Friday, 497 companies set new 52-week lows.
On Tuesday, 298 companies achieved new lows for the year.
Monday saw 196 companies set new 52-week lows.
On Wednesday, 283 companies set new 52-week lows.
Gainers 1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported
During Friday, 125 stocks hit new 52-week lows.
On Tuesday, 120 companies set new 52-week lows.
During Wednesday's trading, 517 companies set new 52-week lows.
During Monday's trading, 528 companies set new 52-week lows.